Work

Effectiveness of an Infliximab Biosimilar vs. Originator in Inflammatory Bowel Diseases

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Clinical Gastroenterology

DOI: 10.1097/mcg.0000000000002263

Authors: Hadas Labrisch-Kaye, Rachel Buchuk, Yiska Weisband, Amir Ben-Tov, Galia Zacay, Eran Metz, Iris Dotan, Dan Turner, Oren Ledder

Institutions: Hebrew University of Jerusalem, Shaare Zedek Medical Center, Bikur Cholim Hospital, Clalit Health Services, Maccabi Healthcare Services, Kupat Holim Meuchedet, Tel Aviv University, Rabin Medical Center

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415292663

FWCI: 0.533

Cites: 21

Cited by: 1

Related to: